相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。18F-FDG uptake in breast cancer correlates with immunohistochemically defined subtypes
Hye Ryoung Koo et al.
EUROPEAN RADIOLOGY (2014)
Predictors of axillary lymph node metastases in early breast cancer and their applicability in clinical practice
Erni Yoshihara et al.
BREAST (2013)
Molecular subtypes of breast cancer: metabolic correlation with 18F-FDG PET/CT
Ana Maria Garcia Vicente et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Comparison Between 18F-FDG PET Image-Derived Indices for Early Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer
Mathieu Hatt et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Accuracy of Predicting Axillary Lymph Node Positivity by Physical Examination, Mammography, Ultrasonography, and Magnetic Resonance Imaging
Stephanie A. Valente et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
18F-FDG Uptake by Metastatic Axillary Lymph Nodes on Pretreatment PET/CT as a Prognostic Factor for Recurrence in Patients with Invasive Ductal Breast Cancer
Bong-Il Song et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
F-18-FDG PET and biomarkers for tumour angiogenesis in early breast cancer
Ashley M. Groves et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Prognostic Value of Primary Tumor Uptake on F-18 FDG PET/CT in Patients with Invasive Ductal Breast Cancer
Bong-Il Song et al.
NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy response
Jorma J. de Ronde et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Breast Cancer Subtypes and the Risk of Local and Regional Relapse
K. David Voduc et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial
Judith Hugh et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
Maggie C. U. Cheang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Selective Sentinel Node Plus Additional Non-Sentinel Node Biopsy Based on an FDG-PET/CT Scan in Early Breast Cancer Patients: Single Institutional Experience
Jeryong Kim et al.
WORLD JOURNAL OF SURGERY (2009)
Tumour molecular subtyping according to hormone receptors and HER2 status defines different pathological complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer
Alfonso Sanchez-Munoz et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2008)
Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes
Christine Desmedt et al.
CLINICAL CANCER RESEARCH (2008)
Clinicopathological and prognostic relevance of uptake level using F-18-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (F-18-FDG PET/CT) in primary breast cancer
Shigeto Ueda et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2008)
Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy
Paul L. Nguyen et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Preoperative staging of large primary breast cancer with [18F] fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures
David Fuster et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Recommendations on the use of F-18-FDG PET in oncology
James W. Fletcher et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Quantitative justification of the change from 10% to 30% for human epidermal growth factor receptor 2 scoring in the American society of clinical Oncology/College of American pathologists guidelines:: tumor heterogeneity in breast cancer and its implications for tissue Microarray based assessment of outcome
Christopher B. Moeder et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial
David N. Krag et al.
LANCET ONCOLOGY (2007)
Prognostic role of the extent of peritumoral vascular invasion in operable breast cancer
M. Colleoni et al.
ANNALS OF ONCOLOGY (2007)
Triple-negative breast cancer: Clinical features and patterns of recurrence
Rebecca Dent et al.
CLINICAL CANCER RESEARCH (2007)
The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes
Lisa A. Carey et al.
CLINICAL CANCER RESEARCH (2007)
A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases
U. Veronesi et al.
ANNALS OF ONCOLOGY (2007)
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
Lisa A. Carey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Fluorodeoxyglucose positron emission tomography with sentinel lymph node biopsy for evaluation of axillary involvement in breast cancer
A Gil-Rendo et al.
BRITISH JOURNAL OF SURGERY (2006)
Surgical complications associated with sentinel lymph node biopsy: Results from a prospective international cooperative group trial
LG Wilke et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas
SM Rodríguez-Pinilla et al.
CLINICAL CANCER RESEARCH (2006)
Twenty-five years of follow-up in patients with operable breast carcinoma - Correlation between clinicopathologic factors and the risk of death in each 5-year period
R Arriagada et al.
CANCER (2006)
p53 protein accumulation predicts resistance to endocrine therapy and decreased post-relapse survival in metastatic breast cancer
Hiroko Yamashita et al.
BREAST CANCER RESEARCH (2006)
Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution
G Viale et al.
CANCER (2005)
Impact of FDG PET on defining the extent of disease and on the treatment of patients with recurrent or metastatic breast cancer
WB Eubank et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2004)
Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: A study by the Cancer and Leukemia Group B
RB Weiss et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
T1 breast cancer:: identification of patients at low risk of axillary lymph node metastases
AA Bader et al.
BREAST CANCER RESEARCH AND TREATMENT (2002)
Gene expression profiling predicts clinical outcome of breast cancer
LJ van't Veer et al.
NATURE (2002)
分享论文
